drugset / Trial / NCT01110590
Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552
RandomizedParallel-groupQuadruple-blind
Summary
Safety, tolerability, pharmacokinetics and pharmacodynamics will be investigated in this multiple dose escalation study. In three treatments groups different dosages of BAY 60-4552 and vardenafil will be given with patients with erectile dysfunction.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-04
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BAY60-4552 | Unknown | 5.25 mg | — |
| Subject | BAY60-4552 | Unknown | 21 mg | — |
| Subject | Vardenafil | Small molecule | 140 mg | — |
| Subject | Vardenafil | Small molecule | 280 mg | — |